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Although recent epidemiologic studies have
demonstrated a correlation between exposure
to ﬁne particulate matter in air pollution and
an increased incidence of cardiovascular mor-
bidity and mortality (Peters et al. 2001; Pope
et al. 2004; Samet et al. 2000), the mecha-
nisms behind this correlation remain largely
unknown. More recently, ultrafine particles
(< 100 nm) have been reported to be particu-
larly relevant pathologically because of their
small size and high reactivity. Of particular
relevance to the present study, ultraﬁne parti-
cles have been shown to cross the pulmonary
epithelial barrier into the bloodstream
(Kreyling et al. 2002; Nemmar et al. 2002,
2003), thereby directly exposing the vascular
endothelium to particles.
Atherosclerosis is a primary cause of many
cardiovascular complications including
myocardial infarctions, ischemia, and stroke.
Acute and chronic inflammation of the
endothelium plays a central role in the
development of atherosclerosis (Libby 2002;
Ross 1999). We hypothesized that exposure of
human aortic endothelial cells (HAECs) to
metal oxide ultrafine particles elicits an
inﬂammatory response and that the nature of
the response depends on the composition of
the particles. To test this hypothesis, we
exposed cultured HAECs acutely to a wide
range of concentrations of iron oxide (Fe2O3),
yttrium oxide (Y2O3), and zinc oxide (ZnO)
nanoparticles for periods of 1–8 hr, and subse-
quently assessed the impact of this exposure
on mRNA and protein levels of specific
inﬂammatory markers. We also used various
imaging and spectrometry techniques to probe
particle interactions with cells. Although all
three types of nanoparticles interact with the
cell surface and are ultimately uptaken into
the intracellular space, induction of the
inflammatory response depends on nano-
particle composition.
Materials and Methods
Synthesis of metal oxide nanoparticles. Fe2O3
nanoparticles were synthesized in an H2/air
diffusion flame seeded with the vapor of
Fe(CO)5 (99.5%; Alfa Aesar, Ward Hill,
MA) using the system described by Guo and
Kennedy (Guo and Kennedy 2004). The
Fe(CO)5 (Fe pentacarbonyl) vapor decom-
posed in the ﬂame to form Fe2O3 nanoparti-
cles. Y2O3 nanoparticles were synthesized in a
similar manner with the vapor of tris(2,2,6,6-
tetramethyl-3,5-heptanedionato)Y(III) (98%;
Alfa Aesar). The yttrium precursor, which
sublimed at moderately high temperature, was
placed in a stainless steel basket in a furnace
and produced a vapor upon heating. ZnO
nanoparticles were synthesized in a similar
H2/air diffusion ﬂame seeded with the vapor
of metal Zn. Zn shots (99.999%; Alfa Aesar)
were placed in a stainless steel furnace that
was heated to approximately 600°C. The
post-flame aerosol containing the particles
was drawn into a sampling tube by vacuum
and the particles were captured on a ﬁlter.
Characterization of nanoparticles. The
metal oxide nanoparticles were characterized
using transmission electron microscopy
(TEM), X-ray diffraction (XRD), and the
Brunauer-Emmett-Teller (BET) technique.
For the TEM and XRD analyses, the
nanoparticles were first extracted from the
membrane filter and suspended in ethanol.
To prepare an XRD sample, the ethanol sus-
pension containing the metal oxide particles
was deposited drop-wise on a single crystal
silicon substrate and dried to obtain a thin
layer of the particles. The XRD samples were
then analyzed in a Scintag PAD V X-Ray
Diffractometer (Thermo Optek, Franklin,
MA) with a Cu Kalpha radiation source oper-
ated at 45 kV and 40 mA. The XRD pat-
terns were analyzed using the MDI JADE
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BACKGROUND: The mechanisms governing the correlation between exposure to ultraﬁne particles
and the increased incidence of cardiovascular disease remain unknown. Ultraﬁne particles appear to
cross the pulmonary epithelial barrier into the bloodstream, raising the possibility of direct contact
with the vascular endothelium.
OBJECTIVES: Because endothelial inflammation is critical for the development of cardiovascular
pathology, we hypothesized that direct exposure of human aortic endothelial cells (HAECs) to
ultrafine particles induces an inflammatory response and that this response depends on particle
composition. 
METHODS: To test the hypothesis, we incubated HAECs for 1–8 hr with different concentrations
(0.001–50 µg/mL) of iron oxide (Fe2O3), yttrium oxide (Y2O3), and zinc oxide (ZnO) nanoparticles
and subsequently measured mRNA and protein levels of the three inflammatory markers intra-
cellular cell adhesion molecule-1, interleukin-8, and monocyte chemotactic protein-1. We also deter-
mined nanoparticle interactions with HAECs using inductively coupled plasma mass spectrometry
and transmission electron microscopy. 
RESULTS: Our data indicate that nanoparticle delivery to the HAEC surface and uptake within the
cells correlate directly with particle concentration in the cell culture medium. All three types of
nanoparticles are internalized into HAECs and are often found within intracellular vesicles. Fe2O3
nanoparticles fail to provoke an inflammatory response in HAECs at any of the concentrations
tested; however, Y2O3 and ZnO nanoparticles elicit a pronounced inﬂammatory response above a
threshold concentration of 10 µg/mL. At the highest concentration, ZnO nanoparticles are cytotoxic
and lead to considerable cell death. 
CONCLUSIONS: These results demonstrate that inﬂammation in HAECs following acute exposure to
metal oxide nanoparticles depends on particle composition.
KEY WORDS: air pollution, atherosclerosis, cardiovascular disease, endothelial cells, inﬂammation,
nanoparticles, particulate matter. Environ Health Perspect 115:403–409 (2007). doi:10.1289/
ehp.8497 available via http://dx.doi.org/ [Online 11 December 2006]6.0 program (Materials Data Inc., Livermore,
CA). To prepare TEM samples, drops of the
ethanol suspension were put on copper TEM
grids with carbon ﬁlm support. After evapo-
ration of the solvent, the metal oxide
nanoparticles were deposited on the grids.
The TEM samples were then analyzed using
a Philips CM-12 microscope (FEI, Hillsboro,
OR) operated at 100 kV. The BET analysis
was conducted on a Gemini 2360 instrument
(Micromeritics, Norcross, GA). Each sample
contained 50- to 100-mg nanoparticles. The
sample was ﬁrst degassed at 300oC to reach a
pressure < 10 µm Hg to remove adsorbed
water; the water content was determined
gravimetrically. The specific surface area of
the nanoparticle samples was then measured
by N2 adsorption/desorption.
Cell culture and exposure to nanoparticles.
HAECs (Cascade Biologics, Portland, OR) in
passages 6–8 were cultured using standard pro-
cedures in Medium 200 (Cascade Biologics)
containing 100 U/mL penicillin G, 100
µg/mL streptomycin, 0.25 µg/mL ampho-
tericin B, and Low Serum Growth Supplement
(LSGS) (Cascade Biologics). LSGS supple-
mentation resulted in medium containing 2%
fetal bovine serum, 1 µg/mL hydrocortisone,
10 ng/mL human epidermal growth factor,
3 ng/mL basic fibroblast growth factor, and
10 µg/mL heparin. In the nanoparticle experi-
ments, conﬂuent HAEC monolayers in stan-
dard 6-well plates were incubated for 1-8 hr at
37°C with Fe2O3, Y2O3, or ZnO nanoparti-
cles in cell culture medium at concentrations
ranging from 0.001 to 50 µg/mL. Prior to
dilution, nanoparticle stock solutions were
sonicated for 5 min to break up aggregates.
HAECs incubated with nanoparticle-free
medium served as controls. 
To determine the impact of nanoparticles
on HAEC viability, cells that were incubated
with the nanoparticles for 4 hr were washed
twice with complete phosphate-buffered saline
(PBS; Invitrogen, Carlsbad, CA) and then
subjected to the trypan blue exclusion assay.
To assess both short- and longer-term impact
of nanoparticle exposure on HAEC viability,
the trypan blue assay was performed immedi-
ately after the 4-hr incubation period as well as
24 hr after the end of incubation (during
which time the cells were incubated in
nanoparticle-free cell culture medium).
Isolation of RNA and reverse transcrip-
tion. Immediately following incubation with
nanoparticles, HAECs were washed with PBS,
detached by trypsinization, and collected by
centrifugation. Total RNA was isolated using
a guanidine isothiocyanate/phenol (TRIzol
Reagent; Invitrogen) and chloroform-based
isolation process in accordance with the
manufacturer’s instructions. The RNA was
subsequently precipitated by isopropanol, and
the final pellet was resuspended in DEPC
(diethylpyrocarbonate) water and stored at
–80°C. cDNAs were prepared from 1 µg total
RNA using the reverse transcriptase enzyme
SuperScript II (Invitrogen) according to the
manufacturer’s instructions. 
Quantitative real-time polymerase chain
reaction (PCR) analysis. We probed transcrip-
tion levels of three inflammatory markers:
intracellular cell adhesion molecule-1
(ICAM-1), monocyte chemotactic protein-1
(MCP-1), and interleukin-8 (IL-8). Human
glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as an internal control.
Primers for these markers were designed by
Primer Express (Applied Biosystems, Foster
City, CA) and purchased from Operon
Technologies (Alameda, CA). Their sequences
were as follows:
ICAM-1 sense: 
5´CAGAAGAAGTGGCCCTCCATAG-3; 
ICAM-1 antisense: 
5´GGGCCTTTGTGTTTTGATGCTA-3; 
MCP-1 sense: 
5´GCCAAGGAGATCTGTGCTGAC-3;
MCP-1 antisense: 
5´CATGGAATCCTGAACCCACTTC-3; 
IL-8 sense: 
5´GTGTAAACATGACTTCCAAGCTGG-3;
IL-8 antisense: 
5´GCACCTTCACACAGAGCTGC-3; 
GAPDH sense: 
5´CACCAACTGCTTAGCACCCC-3; 
GAPDH antisense: 
5´TGGTCATGAGTCCTTCCACG-3.
We conducted quantitative real-time PCR
using the GeneAmp 7900HT Sequence
Detection System (Applied Biosystems). The
reaction was preformed in 96-well Optical
Reaction Plates (Applied Biosystems) with
25 µL of reaction mixture in each well. The
reaction mixture contained samples of cDNA
diluted 1:10, 500 nM of respective sense and
antisense primers, and SYBR Green PCR
Master Mix (Applied Biosystems). The PCR
reaction consisted of initial thermal activation
at 95°C for 10 min and 40 cycles. Each cycle
was as follows: 95°C for 15 sec; 60°C for
1 min. We veriﬁed PCR products by analysis
of heat-dissociation curves and ampliﬁcation
plots. Quantitative values were acquired from
linear regression of the PCR standard curve.
Expression levels for inﬂammatory genes were
then normalized to GAPDH levels for each
sample. 
Western blot analysis. Immediately after
nanoparticle incubation, HAECs were
washed with PBS and then lysed using a lysis
buffer containing M-PER Mammalian
Protein Extraction reagent (Pierce, Rockford,
IL), 2 mM sodium orthovanadate, 5 mM
sodium fluoride, 1 mM phenylmethyl-
sulfonylﬂuoride, 1% protease inhibitor cock-
tail, and 0.1% triton X-100. The cell lysates
were then centrifuged at 14,000 × g for 5 min
at 4°C, and SDS-PAGE was performed on a
7.5% Tris-HCl gel (Bio-Rad Laboratories,
Hercules, CA). Proteins were then transferred
onto a nitrocellulose membrane. The mem-
brane was blocked with 5% blotto non-fat
milk (Santa Cruz Biotechnology, Santa Cruz,
CA) and incubated overnight at 4°C with rab-
bit polyclonal anti-ICAM-1 (Santa Cruz
Biotechnology) and mouse monoclonal anti-
β-actin (Sigma Chemical Company, St. Louis,
MO) primary antibodies. After incubation
with respective secondary antibodies conju-
gated with horseradish peroxidase (HRP),
HRP was visualized using ECL Western
Detection Reagent (Amersham, Pittsburgh,
PA) and developed on a CL-XPosure film
(Pierce). We performed protein analysis using
Kodak 1D Image Analysis Software (Eastman
Kodak Company, Rochester, NY). Band den-
sities of ICAM-1 were normalized by the
band density of β-actin, which served as an
internal control.
ELISA analysis. Immediately after the
nanoparticle incubation period, we collected
cell culture supernatants and centrifuged them
at 16,000 × g for 5 min to remove cell debris
and particles. We assayed MCP-1 protein con-
centrations in the supernatants using an ELISA
kit (Quantikine Human MCP-1/CCL2
Immunoassay, R&D Systems, Minneapolis,
MN) according to the manufacturer’s
instructions. 
TEM. HAECs exposed to nanoparticles
for 4 hr were washed with PBS and ﬁxed with
Karnovsky’s EM fixative (2.5% glutaralde-
hyde and 2% paraformaldehyde in 80 mM
phosphate buffer, pH 7.3–7.4). Secondary
fixation was done in 1% osmium tetroxide
with 1.5% potassium ferrocyanide in double
distilled H2O for 1 hr at 4°C. Dehydration
was through ascending concentrations of
ethanol with three changes at 100%. Pure
Epon-Araldite resin that did not contain
methyl anhydride was added and infiltrated
overnight at room temperature. All resin was
removed the next day, and fresh resin was
added to the appropriate depth. The sample
was polymerized for 18 hr. Ultrathin sections
of cells of interest were cut en face (parallel to
the surface on which the cells were grown)
using a Leica Ultracut UCT ultramicrotome
(Leica Mikrosysteme Gmbh, Vienna, Austria)
and then stained with uranyl acetate and lead
citrate before viewing in a Philips CM120
electron microscope (FEI).
Inductively coupled plasma mass spectrom-
etry. We measured the delivery of the metal
oxide nanoparticles to the cell surface and the
uptake of nanoparticles by the cells using
inductively coupled plasma mass spectrometry
(ICP-MS). Conﬂuent HAECs in 6-well plates
were exposed to nanoparticles for 4 hr, washed
with PBS, and detached. The cell pellet was
resuspended in 0.5 mL Hanks’ Balanced Salt
Gojova et al.
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of cells was established using a hemacytometer
(Bright-Line; Hausser Scientific, Horsham,
PA). The solutions were mixed with concen-
trated nitric acid (HNO3; EMD Chemicals,
Gibbstown, NJ) to reach a ﬁnal HNO3 con-
centration of 3%, and then heated to 80°C for
3 hr to dissolve cell content. We prepared a
blank control solution for ICPMS reaction
(without cells) by mixing 0.5 mL HBSS with
the same amount of concentrated HNO3; this
solution was processed the same way as the
sample solutions. Finally, the dissolved solu-
tions were adjusted to a volume of 25 mL with
3% HNO3 in water and used for ICP-MS
analysis. The concentrations of Fe, Y, and Zn
were determined using an Agilent Technologies
7500c inductively coupled plasma mass spec-
trometer (Agilent Technologies, Santa Clara,
CA). The precision of the analysis was better
than ± 3.8%.
Statistical analysis. Data are presented as
mean ± SE. Statistical analyses were performed
by one-way analysis of variance followed by
Dunnett post hoc test. Differences in means
were considered signiﬁcant if p < 0.05.
Results
Particle characteristics and uptake. Repre-
sentative TEM images of the metal oxide
nanoparticles are shown in Figure 1. XRD and
TEM analysis revealed that the Fe2O3
nanoparticles exhibit the crystal structure of
γ-Fe2O3, or maghemite, and can be divided
into two size groups (Figure 1A). To further
characterize the Fe2O3 particles, we used a
Scanning Mobility Particle Sizer (SMPS; TSI
Incorporated, Shoreview, MN), consisting of a
3071A Differential Mobility Analyzer (DMA)
and a 3025A Condensation Particles Counter
(CPC), for online particle size analysis.
Consistent with the TEM images, the SMPS
analysis demonstrated that Fe2O3 particles
contain two size modes. Particles in the larger
mode are nonagglomerated and nearly spheri-
cal, and appear to have a log-normal size distri-
bution. Based on the SMPS and TEM surveys,
the count median diameter (CMD) of the log-
normal size distribution is approximately
45 nm, with a geometric standard deviation
(GSD) of approximately 1.2. The particles in
the small mode are nearly monodisperse with
an estimated mean diameter of approximately
5 nm. Our SMPS could not resolve the small
mode of the Fe2O3 particle size distribution
and hence we resorted to the use of direct
physical surface areas via the BET method,
along with an analysis of the resolved size dis-
tribution of the larger particles to infer the con-
tributions of each mode to number, surface
area, and mass of the combined bimodal
aerosol. The ratio of number concentration of
the smaller mode to the larger mode can be
calculated using the following equation:
[1]
where dm –_Large is the diameter of particles
with average mass for the large mode,
which—calculated from the CMD and GSD
of the assumed log-normal distribution (Hinds
1999)—is approximately 47 nm; dSmall is the
estimated diameter for the assumed monodis-
perse small mode, approximately 5 nm; RS/L is
the number concentration ratio of the small
mode to the large mode; (S/M)BET is the BET-
specific surface area measured for the Fe2O3
particles, large and small modes both included,
81 ± 1 m2/g; and ds –_Large is the diameter of
particles with average surface area for the large
mode, which—calculated from the CMD and
GSD of the log-normal distribution (Hinds
1999)—is approximately 47 nm. The equation
can be solved to yield a value of approximately
330 for RS/L, indicating that for every particle
in the large mode there are approximately 330
particles in the small mode. The results also
indicate that the small mode accounts for
approximately 28% of the particle mass and
approximately 79% of the particle surface area.
The Y2O3 nanoparticles have a C-type
cubic structure with primary particle sizes in
the range of 20–60 nm (Figure 1B). The
ZnO nanoparticles have a zincite crystal
structure and are rod-shaped, with lengths of
100–200 nm and diameters of 20–70 nm
(Figure 1C). The smaller size mode present in
the case of Fe2O3 nanoparticles is not evident
in the TEM images of the Y2O3 or ZnO par-
ticles. The particle size distribution of the
Y2O3 and ZnO particles was not measured
using the SMPS because of difﬁculty in dilut-
ing the flame-generated aerosols. The BET-
specific surface areas for the Fe2O3, Y2O3,
and ZnO nanoparticles were 81 ± 1, 41 ± 1,
and 20.8 ± 0.2 m2/g, respectively.
Although some of the particles in Figure 1
appear as aggregates, it is difﬁcult to infer the
state of aggregation of particles from the TEM
images. In acquiring the TEM images, sam-
ples of particles were dispersed in suspension
and then dropped onto TEM grids and dried.
This process inevitably leads to the appearance
of aggregates as the sample dries; therefore,
one must remain cautious about interpreting
the images as indicative of aggregation in the
dispersed phase. As described in “Materials
and Methods,” particle stock solutions were
sonicated for 5 min prior to preparing the
final working concentrations; however, it is
possible that some particle agglomeration
occurs during the course of exposure to cells,
even after dispersion with a sonicator.
ICP-MS measurements revealed that the
amount of metal uptake correlated directly
with the concentration of metal oxide in the
extracellular solution for all three types of
nanoparticles (Figure 2). These results indicate
a clear dose-dependent uptake of the metal
Nanoparticle-induced inflammation in endothelium
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Figure 1. TEM images of metal oxide nanoparticles.
(A)F e 2O3; arrows point to the subpopulation of parti-
cles with a size < 5 nm. (B)Y 2O3. (C) ZnO.
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Figure 2. ICP-MS measurements of metal uptake by
HAECs as a function of the metal oxide concentration
in the extracellular solution for the three different
types of nanoparticles. 
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oxide nanoparticles by HAECs and show that
nanoparticle concentration within the cell
culture medium provides an accurate meas-
ure of the particle dose delivered to the cell
surface.
Thin-section TEM images of cells. Thin-
section TEM images show that after 4 hr incu-
bation Fe2O3 nanoparticles were incorporated
into HAECs at all concentrations tested
(0.001–50 µg/mL); the number of nanoparti-
cles in a cell increased with concentration.
Identification of Fe2O3 nanoparticles inside
the cells was straightforward because the parti-
cles maintained their faceted feature. The
Fe2O3 nanoparticles were often present within
cytoplasmic vesicles (Figure 3A). No signiﬁcant
swelling was observed in the vesicles containing
Fe2O3 nanoparticles.
Objects with high electron density were
found in the thin-section TEM images of
HAECs treated with Y2O3 nanoparticles. As
with Fe2O3 nanoparticles, these objects were
often present within cytoplasmic vesicles
(Figure 3B), and their density increased with
nanoparticle concentration. Although they did
not have the characteristic morphology of the
original Y2O3 nanoparticles (Figure 1B) and
despite the lack of elemental analysis to con-
firm their chemical composition, these high
electron density objects are presumably the
products of the degradation of the Y2O3
nanoparticles, because no other elements of
comparable electron density should be present
in these thin sections and the objects were not
observed in the control sample (Figure 3D).
The vesicles containing these objects exhibited
considerable swelling, particularly at the higher
Y2O3 nanoparticle concentrations (Figure 3B). 
Thin-section TEM images of HAECs
treated with ZnO nanoparticles showed fewer
intracellular vesicles (Figure 3C). High elec-
tron density particulate matter was observed
in the vicinity of the cell membrane. Such
particulate matter was not seen in the control
(untreated) cells (Figure 3D). In some
instances, apparent discontinuities in the cell
membrane were observed in HAECs treated
with ZnO nanoparticles.
Effect of nanoparticles on HAEC inﬂam-
mation and viability. Incubating HAECs for
4 hr with Fe2O3 nanoparticles failed to
induce an increase in ICAM-1, IL-8, or
MCP-1 mRNA levels relative to control cells
(Figure 4A). For instance, the ICAM-1, IL-8,
and MCP-1 mRNA levels of HAECs incu-
bated with 50 µg/mL Fe2O3 nanoparticles
were 0.8 ± 0.2, 0.8 ± 0.2, and 0.7 ± 0.1 times
control values, respectively (p > 0.05). In con-
trast, 4-hr incubation with Y2O3 nanoparticles
induced an increase in ICAM-1, IL-8, and
MCP-1 mRNA levels. The effect of Y2O3
nanoparticles was concentration dependent,
with a statistically significant increase at the
two highest concentrations: 10 and 50 µg/mL
(Figure 4B). At 50 µg/mL, Y2O3 nanoparticles
Figure 3. Thin-section TEM images of HAECs incubated with metal oxide nanoparticles. (A)F e 2O3. (B)Y 2O3.
(C) ZnO. (D) Control (no nanoparticles). Abbreviations: n, nucleus; v, vesicle; black star, normal continuous
cell membrane; white star, region of possible cell membrane discontinuity. Arrows denote metal oxide
particles or particulate matter.
A B
C D
2 μm
5 μm
10 μm
200 nm
Figure 4. mRNA levels of the three inﬂammatory markers ICAM-1, IL-8, and MCP-1 in HAECs incubated for 4 hr with Fe2O3 (A), Y2O3 (B), or ZnO (C) nanoparticles.
Each mRNA value was normalized to corresponding GAPDH value. Ratios relative to control cells (no nanoparticles) are shown; data are mean ± SE from three
independent experiments run in duplicates. 
*Statistically signiﬁcant mRNA level increase relative to control cells (p < 0.05).
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ZnO concentration (μg/mL)increased ICAM-1, IL-8, and MCP-1 mRNA
levels relative to control cells by 5.3 ± 0.6, 3.3 ±
0.5, and 6.8 ± 1.6 times, respectively (p < 0.05
for all three markers). At 10 µg/mL, the equiva-
lent mRNA up-regulation values were 2.2 ±
0.3, 1.2 ± 0.3, and 2.2 ± 0.1 for ICAM-1, IL-8,
and MCP-1, respectively (p < 0.05 for
ICAM-1; p > 0.05 for MCP-1 and IL-8).
ZnO nanoparticles had the most striking
effect on HAECs. At the two highest concen-
trations, ZnO nanoparticles provoked consid-
erable cell death at the end of the 4-hr
incubation period. This was unlike the Fe2O3
and Y2O3 nanoparticles, which did not lead
to visible cell loss after 4 hr of incubation. At
50 µg/mL, cell loss after 4 hr ZnO incubation
was approximately 50%; at 10 µg/mL, cell
loss was approximately 20%. No cell loss was
noted at the lower concentrations. An 8-hr
incubation period did not result in additional
cell loss. HAECs remaining attached follow-
ing incubation with ZnO nanoparticles
showed similar viability rates as assessed by
trypan blue exclusion to those of control cells
and cells exposed to the other two types of
nanoparticles. More specifically, HAEC via-
bility rates after 4-hr incubation were as fol-
lows (n = 3 and p > 0.05 relative to control in
all cases): 88 ± 1% for control cells; 89 ± 1%
and 82 ± 3% for ZnO nanoparticles at 10
and 50 µg/mL, respectively; 88 ± 2% and 88
± 4% for Y2O3 particles at 10 and 50 µg/mL,
respectively; and 88 ± 4% and 92 ± 3% for
Fe2O3 particles at 10 and 50 µg/mL, respec-
tively. Largely similar viability rates were
obtained after 8 hr of incubation.
To assess the longer-term impact of ZnO
nanoparticles on HAEC viability, cells were
incubated with these particles at either 10 or
50 µg/mL for 4 hr, washed with PBS three
times, and then maintained another 24 hr in
cell culture medium free of nanoparticles.
Although this protocol did not lead to a sig-
niﬁcant decrease in cell viability at 10 µg/mL
(89 ± 2% vs. 90 ± 1% for control cells; n =4 ,
p > 0.05), viability significantly decreased at
50 µg/mL (71 ± 7%; n = 4, p < 0.05 relative
to control). However, there are technical difﬁ-
culties associated with the protocol. We
found it very difﬁcult to fully remove particles
from the cell surface by washing, especially at
the higher particle concentrations. Therefore,
the particles that remained attached after
washing may have continued to inﬂuence cell
viability during the ensuing 24-hr period.
ZnO nanoparticles also elicited an inﬂam-
matory reaction in HAECs in a concentration-
dependent manner (Figure 4C). At 50 µg/mL,
ICAM-1, IL-8, and MCP-1 mRNA levels
increased relative to control cells by 13.6 ±
4.1, 6.4 ± 2.5, and 10.8 ± 6.2 times, respec-
tively. The equivalent values for 10 µg/mL
were 17.9 ± 2.1, 5.2 ± 2.2, and 4.0 ± 0.6.
To elucidate the temporal evolution of
transcriptional inﬂammatory changes induced
by nanoparticles, we studied ICAM-1, IL-8,
and MCP-1 mRNA levels at three additional
time points: 1, 2, and 8 hr. Because the 4-hr
data had demonstrated that the critical con-
centration threshold required for inducing an
inflammatory response was between 1 and
10 µg/mL (Figure 4), these two concentrations
were selected for the experiments at the addi-
tional time points. At the 1- and 2-hr time
points, only ZnO nanoparticles at 10 µg/mL
increased ICAM-1, IL-8, and MCP-1 mRNA
levels significantly (Figure 5A, 5B). This
increase persisted at the 8-hr time point and
was also accompanied by a more modest
increase in ICAM-1 and MCP-1 mRNA in
HAECs incubated with Y2O3 nanoparticles at
10 µg/mL (Figure 5C). Fe2O3 nanoparticles
failed to elicit inﬂammation at any of the time
points or concentrations tested.
Although ZnO nanoparticles altered the
transcriptional expression of all three inﬂam-
matory markers, the dynamics of this increase
were different for the different markers.
Although ICAM-1 mRNA levels increased
between the 1- and 2-hr time points and then
remained at this elevated level, IL-8 and
MCP-1 mRNA expression peaked at 2 hr and
then decreased to considerably lower levels
(though signiﬁcantly higher than control levels)
at the 4- and 8-hr time points.
In addition to the transcriptional response,
the up-regulation of inﬂammatory markers by
nanoparticles was also observed at the transla-
tional (protein) level. We used Western blot
analysis to probe ICAM-1 protein levels in
HAECs following 4-hr incubation with
nanoparticles (Figure 6A). Fe2O3 and Y2O3
nanoparticles failed to increase ICAM-1 pro-
tein at any of the concentrations tested. On
the other hand, ZnO nanoparticles at 10 and
50 µg/mL increased ICAM-1 protein levels
relative to control cells by 1.8 ± 0.5 and 2.2 ±
0.6 times, respectively (p = 0.06 for 10 µg/mL
and p < 0.05 for 50 µg/mL). We also meas-
ured MCP-1 protein concentration in cell
culture supernatants of HAECs incubated
with nanoparticles for 4 hr using ELISA
(Figure 6B). In line with the mRNA results,
Fe2O3 nanoparticles did not increase MCP-1
levels. At 10 and 50 µg/mL, Y2O3 nano-
particles increased MCP-1 protein levels rela-
tive to control cells by 1.5 ± 0.1 and 3.2 ± 0.5
times, respectively (p > 0.05 for both). Similar
concentrations of ZnO nanoparticles increased
MCP-1 concentrations by 8.0 ± 1.1 and 6.8 ±
1.2 times (p < 0.05 for both). A concentration
of 1 µg/mL failed to evoke a significant
increase in MCP-1 protein levels for all three
types of nanoparticles.
Role of released metals and impurities in
HAEC inﬂammation. A question that arises is
whether the inﬂammatory response is due at
least in part to the release of reactive metal
species from the nanoparticles. To address
this issue, we performed limited experiments
in which cell culture medium incubated for
4 hr with Fe2O3, Y2O3, or ZnO nanoparticles
(at either 10 or 50 µg/mL) was centrifuged to
remove most nanoparticles, and the super-
natant was then added to HAECs for another
4 hr. For all three types of nanoparticles,
ICAM-1, IL-8, and MCP-1 mRNA levels
were virtually identical to those of control
Nanoparticle-induced inflammation in endothelium
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Figure 5. mRNA levels of the three inﬂammatory markers ICAM-1, IL-8, and MCP-1 in HAECs incubated with nanoparticles (1 and 10 µg/mL) for 1 hr (A) ,  2h r( B),
and 8 hr (C). Each mRNA value was normalized to corresponding GAPDH value. Ratios relative to control cells (no nanoparticles) are shown; data are mean ± SE
from three independent experiments run in duplicates. 
*Statistically signiﬁcant mRNA level increase relative to control cells (p < 0.05).
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cells (data not shown). These ﬁndings suggest
that the observed inflammatory response is
due to the presence of the particles rather
than released reactive metals.
We also determined the detailed metal
composition of all three types of nanoparticles
using ICP-MS. The results demonstrated that
the synthesized nanoparticles were pure
because concentrations for the vast majority
of metals were below the detection limit for
all three types of nanoparticles. In the few
cases where trace metal impurities were
detected, they were at concentrations on the
order of 0.01 ppb (very close to the detection
limit; data not shown). 
Discussion
The mechanisms governing the epidemiologic
correlation between exposure to ultrafine 
particles and increased incidence of cardio-
vascular disease remain unknown. Because
endothelial inﬂammation is a critical early event
in vascular pathology, we studied the impact of
nanoparticles on inﬂammation in HAECs. Our
results demonstrated that direct and acute expo-
sure of HAECs to Y2O3 or ZnO nanoparticles
signiﬁcantly up-regulates mRNA levels of the
inflammatory markers IL-8, ICAM-1, and
MCP-1, whereas Fe2O3 particles have no
effect. The mRNA up-regulation is larger for
ZnO than for Y2O3. Whenever it occurs, the
inﬂammatory response does not initiate below
a particle concentration of approximately
10 µg/mL and is dose-dependent above this
threshold concentration. At the highest con-
centration (50 µg/mL), ZnO nanoparticles
lead to considerable cell toxicity in addition to
the pronounced inﬂammatory response.
A key ﬁnding of the present study is that
metal oxide nanoparticle composition is a
major determinant of propensity to induce
inflammation in HAECs; however, the
mechanistic basis of this observation remains
unknown. The dependence of endothelial
inﬂammation on nanoparticle composition is
not attributable to differences in the ability of
the different types of particles to access the cell
surface or to get internalized within the intra-
cellular space. Our results show that all three
types of metal oxide nanoparticles are internal-
ized within HAECs and that a given particle
concentration in the cell culture medium leads
to a related dose delivered to the cells.
Therefore, it is more likely that nanoparticle
type may inﬂuence the inﬂammatory response
through a dependence of specific inflamma-
tion-signaling pathways on particle composi-
tion. Interestingly, HAEC inflammation
appears to correlate inversely with nanoparti-
cle-specific surface area, although this issue
needs to be studied more systematically in
future studies. Fe2O3 nanoparticles, which
have the largest speciﬁc surface area among the
three types of particles tested (as shown by
BET measurements), fail to elicit inflamma-
tion, whereas ZnO nanoparticles have the
smallest speciﬁc surface area and provoke the
most pronounced inﬂammatory response.
We determined that the possible release of
reactive metal species from the nanoparticles
does not contribute significantly to the
inﬂammatory response in HAECs. This result
is consistent with previous findings that
although nickel and cobalt ions elicit
ICAM-1, E-selectin, IL-6, and IL-8 produc-
tion in human umbilical vein endothelial cells
(HUVECs) (Wagner et al. 1998), nickel
nanoparticles have virtually no impact on
HUVEC inflammation or toxicity (Peters
et al. 2004). A recent study demonstrating
that the release of soluble components is not
responsible for the inﬂammatory properties of
carbon black nanoparticles (Brown et al.
2000) further corroborates the notion that the
impact of free metal release from nanoparticles
on inﬂammation is minimal. 
An obvious candidate pathway for
nanoparticle-induced inﬂammation in HAECs
is the production of reactive oxygen species
(ROS). Exposure to nanoparticles is generally
thought to elicit ROS generation and cellular
oxidative stress (Donaldson et al. 2001; Nel
et al. 2006); however, a recent report has sug-
gested that cerium oxide and Y2O3 nanoparti-
cles act as antioxidants in neurons (Schubert
et al. 2006). In preliminary studies, we tested
the impact of Fe2O3, Y2O3, and ZnO
nanoparticles (1, 10, and 50 µg/mL for 1, 2,
and 4 hr) on HAEC ROS levels using the ﬂuo-
rescent indicator 5-(and-6)-chloromethyl-
2´,7´dichlorodihydrofluorescein diacetate,
acetyl ester (Invitrogen). Visual inspection of
the images could not positively confirm the
presence of ROS; quantiﬁcation of these results
proved difficult because of the high back-
ground fluorescence in the images. Further
studies with more sensitive reagents are needed
to definitively establish a link between ROS
formation and the inﬂammatory responses that
we observed, if in fact ROS is responsible.
Reactive nitrogen species may also be involved
in endothelial inflammation induced by
nanoparticles. Interestingly, a recent study has
demonstrated that exogenous Zn elicits an
endothelial stress response that resembles that
of nitric oxide-mediated nitrosative stress
(Wiseman et al. 2006).
We focused on Fe2O3, Y2O3, and ZnO
nanoparticles as examples of metal oxides
that are associated with environmental and
occupational exposures. Huggins et al.
(2000) analyzed Standard Reference Material
(SRM) urban and diesel engine particulate
matter (National Institute of Standards and
Technology, Gaithersburg, MD) for metal
content. They found that Fe and Zn were the
most abundant metals following potassium
and calcium in both types of samples.
Yttrium is widely used in catalysts and is also
used as a host material for phosphors that are
used in lighting and computer displays. The
three metals also provide a range of properties
of their oxides, especially reactivity and solu-
bility in acidic environments that might be
found in cytoplasmic vesicles in endothelial
cells (Ollinger and Brunk 1995; Spragg et al.
1997). Future studies should test if differ-
ences in the propensity of different metal
oxide nanoparticles to induce inflammation
may relate to the reactivity of the metal oxides
in acidic environments.
Recent studies have focused on using
nanoparticles for targeted drug delivery to cells
and for visualizing intracellular processes
(Panyam and Labhasetwar 2003; Pitsillides
et al. 2003). These studies investigated nano-
particle uptake by cells but did not address in
Figure 6. Protein levels of ICAM-1 (A) and MCP-1 (B)
in HAECs incubated with nanoparticles (1, 10, and
50 µg/mL) for 4 hr. (A) Representative Western blot
and densitometric analyses of ICAM-1 protein lev-
els. ICAM-1 band densities are normalized to the
internal control (β-actin); data are mean ± SE from
3–6 independent experiments. (B) ELISA results for
MCP-1 protein levels relative to control cells (no
nanoparticles); data are mean ± SE from 3–4 inde-
pendent experiments. 
*Statistically significant protein level increase relative to
control cells (p < 0.05).
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pathology. Previous studies have demonstrated
that exposure to ultrafine particles induces
inﬂammation in pulmonary epithelial cells and
within the lung in general (Dagher et al. 2005;
Schaumann et al. 2004). However, very few
studies have addressed the impact of ultraﬁne
particles on vascular cells. In vivo, inhalation of
particulate matter–laden air has been shown to
induce release of endothelin-2 in rats (Elder
et al. 2004). In vitro, incubation of HUVECs
with particulate matter collected from air sam-
pling has been reported to increase E-selectin
production (Alfaro-Moreno et al. 2002). More
recently, Peters et al. (2004) reported that
direct exposure of dermal microvascular
endothelial cells to metal nanoparticles
decreases cellular viability and induces IL-8
expression. Interestingly, the response was
dependent on nanoparticle composition: it was
more pronounced for cobalt particles than for
either silicon dioxide or titanium dioxide parti-
cles and was absent for nickel and polyvinyl
chloride particles. Finally, in a recent study,
Yamawaki and Iwai (2006) demonstrated that
carbon black nanoparticles (at concentrations
of up to 100 µg/mL) alter HUVEC morphol-
ogy and increase MCP-1 protein levels in a
dose-dependent fashion, similar to the ZnO
and Y2O3 nanoparticles in the present study.
In the present study, we examined the
effect of a wide range of nanoparticle concen-
trations on HAEC inﬂammation. The fraction
of inhaled particles that ultimately cross the
pulmonary epithelial barrier into the cardio-
vascular system is not definitively known;
therefore, particle concentrations to which
endothelial cells are exposed in vivo remain to
be determined. Some animal studies suggest
that particles translocating to extrapulmonary
organs account for a small fraction (< 1%) of
those deposited in the lungs (Kreyling et al.
2002). On the other hand, other studies have
reported that approximately 10–15% of
inhaled titanium oxide nanoparticles end up
within the vascular compartment (Geiser et al.
2005). In a reported case of human Zn fume
fever (Noel and Ruthman 1988), the serum
Zn level was elevated from 1.1 to 1.6 µg/mL. If
the excess Zn were in the form of ZnO parti-
cles, the increase would correspond to a ZnO
concentration of 0.5 µg/mL in the blood-
stream. Although this value falls below the
threshold required to induce inflammation
reported here (~ 10 µg/mL), it is essential to
recognize that, in the present study, we focused
exclusively on acute exposure (1–8 hr).
Although the results of acute studies are critical
in light of the observation that many of the
cardiovascular events correlated with particu-
late matter exposure occur within a few hours
of exposure (Peters et al. 2001), inﬂammation
induced by inhaled/translocated particles likely
persists for years. Therefore, particles that are
identified in acute studies to mediate an
inflammatory response can subsequently be
tested at lower doses to evaluate their chronic
effect. 
In the present study we focused on nano-
particle interactions with endothelium under
static conditions. Endothelial cells in vivo are
constantly exposed to flow, and there is
mounting evidence that fluid mechanical
forces regulate endothelial inﬂammation. Flow
is also expected to alter the rate of delivery of
nanoparticles to the endothelial cell surface
and the particle interaction time with the cell
surface. Therefore, future studies performed
under ﬂow promise to provide a more physio-
logically relevant understanding of endothelial
cell inflammation induced by nanoparticles.
Finally, it would be important to establish if
the present results obtained from endothelial
monolayers in culture also apply to the in vivo
environment. Animal studies of the impact of
nanoparticles on vascular inﬂammation should
help address this question.
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